Cargando…
Update on the urotensinergic system: new trends in receptor localization, activation, and drug design
The urotensinergic system plays central roles in the physiological regulation of major mammalian organ systems, including the cardiovascular system. As a matter of fact, this system has been linked to numerous pathophysiological states including atherosclerosis, heart failure, hypertension, diabetes...
Autores principales: | Chatenet, David, Nguyen, Thi-Tuyet M., Létourneau, Myriam, Fournier, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533682/ https://www.ncbi.nlm.nih.gov/pubmed/23293631 http://dx.doi.org/10.3389/fendo.2012.00174 |
Ejemplares similares
-
Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
por: Dao, Myriam, et al.
Publicado: (2021) -
Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands
por: Nassour, Hassan, et al.
Publicado: (2021) -
Invertebrate Gonadotropin-Releasing Hormone-Related Peptides and Their Receptors: An Update
por: Sakai, Tsubasa, et al.
Publicado: (2017) -
Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity
por: Thamri, Amal, et al.
Publicado: (2017) -
Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
por: Vladoiu, Maria Claudia, et al.
Publicado: (2015)